Lumpectomy News and Research

RSS

Study: Breast cancer reduction efforts show mixed progress

The data is clear: for patients with early stage breast cancer, certain operations risk more harm than good -; increasing the risk of medical complications, missed work and health care costs without increasing survival rates.

10 Jun 2020

Monoclonal antibody therapy achieves modest reduction in recurrence for patients with HER2-positive DCIS

The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43.

29 May 2020

Cancer patients face treatment delays and uncertainty as coronavirus cripples hospitals

The federal government has encouraged health centers to delay nonessential surgeries while weighing the severity of patients' conditions and the availability of personal protective equipment, beds and staffing at hospitals.

7 Apr 2020

Study provides new evidence about optimal way to treat BRCA carriers with breast cancer

Commonly known as the breast cancer genes, the BRCA gene family plays a role in repairing damaged DNA. Inherited mutations in the genes BRCA1 or BRCA2 raise the risk of developing breast, ovarian, prostate and other cancers.

5 Mar 2020

One in five operations with in-network surgeons and facilities could result in surprise bills

As if recovering from surgery wasn't hard enough, a new study shows that one in five operations could result in an unwelcome surprise: a bill for hundreds or thousands of dollars that the patient didn't know they might owe.

11 Feb 2020

Clinical study demonstrates effective alternative to mastectomy for recurrent breast cancer

Mastectomy has historically been the standard treatment for breast cancer patients experiencing recurrence after an initial lumpectomy and whole-breast radiation. Now, a phase 2 clinical trial led by Douglas W. Arthur, M.D., chair and professor in the Department of Radiation Oncology at VCU Massey Cancer Center and VCU School of Medicine, has demonstrated an effective alternative.

18 Dec 2019

Radiation therapy alone found to be cost-effective for treatment of DCIS

Ductal carcinoma in-situ (DCIS) accounts for one-fifth of breast cancer cases in the United States, according to the American Cancer Society.

11 Dec 2019

Genetic testing results help woman to make decisions about her treatment and preventive care

Wendy Richardson, 52, of Ridgefield, Connecticut, has always been aware that she has a strong family history of cancer.

3 Dec 2019

Research asserts ability of DRS technique to characterize healthy and non-healthy tissue

In an article published in the peer-reviewed SPIE publication Journal of Biomedical Optics (JBO), "Influence of neoadjuvant chemotherapy on diffuse reflectance spectra of tissue in breast surgery specimens," research observed across 92 ex vivo breast specimens suggests that there is little to no impact on the optical signatures of breast tissue after neoadjuvant chemotherapy.

27 Nov 2019

Breast-conserving treatment may be a viable alternative to mastectomy, study suggests

Approximately 10% of breast cancer patients treated with lumpectomy (breast-conserving surgery [BCS]) and whole-breast radiation (WBI) will have a subsequent in-breast local recurrence of cancer (IBTR) when followed long term.

22 Nov 2019

New research could help better understand progress of breast cancer

New research at Case Western Reserve University could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

29 Oct 2019

Older women with DCIS gain no benefit from sentinel lymph node biopsy

Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS) gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has spread, new research by the Yale School of Public Health has found.

24 Oct 2019

Survey quantifies cancer patients' interest in pathology services

Some of the most important players on a cancer patient's health care team are people they typically never meet or interact with - the pathologists who evaluate their tissue samples to determine the type and stage of disease they have.

10 Oct 2019

Women under 40 often choose aggressive surgery out of fear of second breast cancer

Yes, it's not common. Breast cancer among women under 40 is rare. No matter the age, a cancer diagnosis causes anxiety and fear. In addition, women in their 20s and 30s face some unique challenges and daunting decisions. Deciding what type of surgery to have is one of them.

3 Oct 2019

Lumpectomy is less invasive surgery and requires no hospitalization, shows study

It is well established that breast conservation, which involves the removal of a breast cancer along with a small rim of normal breast tissue around it and is followed by radiation therapy, is at least as effective as mastectomy (removal of the whole breast) for the treatment of early breast cancer.

27 Sep 2019

Partial, whole breast radiation after lumpectomy yield similar cosmetic outcomes

Whole breast radiation and partial breast radiation following a lumpectomy yield similar cosmetic outcomes for women diagnosed with early stages of cancer who wish to preserve their breasts.

26 Sep 2019

Study examines racial disparities in survival outcomes of pediatric patients with Hodgkin lymphoma

In what is believed to be the largest dataset study to date examining the role of race on survival outcome for pediatric patients with Hodgkin lymphoma, investigators at Rutgers Cancer Institute of New Jersey have found that black patients have significantly worse overall survival at five years than white patients when accounting for all available clinical variables.

18 Sep 2019